Watch for Patients Taking the New Oral Multiple Sclerosis Meds
You'll see new ORAL meds to treat multiple sclerosis (MS) hit home med lists.
We're used to seeing the injectables (Avonex, Copaxone, etc) first-line. Or patients with more severe disease may jump right to a monoclonal antibody IV infusion (Lemtrada, Tysabri, etc).
But watch for the new options when patients prefer an oral med...or don't tolerate injectables.